SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals is trending following its recent FDA approval for Aqvesme, positioning it as the sole approved treatment for alpha- and beta-thalassemia. This significant regulatory milestone is sparking community discussion around its market potential and expected impact, driving considerable trading activity despite past investor concerns regarding other pipeline developments.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is drawing significant attention as its circulating supply nears its maximum cap, fueling expectations of a potential 'supply shock' and treasury buybacks among bullish investors. This optimism is sharply contrasted by widespread community concerns regarding the Compound Foundation's financial health, governance challenges, and strong competition within the DeFi lending space.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

AVNT CRYPTO is actively trending with heightened discussion and trading volume, significantly fueled by its recent listing on Robinhood and strategic backing by Coinbase's Base app. Community sentiment is deeply divided, with many anticipating a substantial price rally due to these developments, while a vocal segment expresses skepticism over perceived "rug pulls," token unlocks, and concerns about leadership, intensifying the debate around its market trajectory. Investors are weighing its potential as a leading perp DEX against rivals, highlighting a dynamic and contentious trading environment.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroup is currently trending as a leading bank stock, driven by significant regulatory progress and ongoing strategic initiatives, including a major wealth management partnership and advancements in digital assets. The community is actively discussing its substantial price appreciation and perceived undervaluation, while some caution about its rapid ascent and overbought technical indicators.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax Technologies (DVAX) is actively discussed after Sanofi announced an agreement to acquire the company for $15.50 per share, significantly boosting DVAX's trading volume and prompting a strong price surge. The acquisition, which integrates DVAX's hepatitis B vaccine and a promising shingles candidate into Sanofi's portfolio, has sparked varied community reactions; while some long-term investors voice disappointment over the perceived low valuation, others welcome the deal as a solid exit and a realized gain.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros (OMER) is trending following the FDA approval of YARTEMLEA, its first-in-class therapy for transplant-associated thrombotic microangiopathy (TA-TMA). Investors are celebrating this significant milestone, anticipating substantial upside potential given the drug's unique market position and the company's strengthened financial outlook from a major licensing deal. The community is actively discussing a potential re-rating of the stock and speculation around a possible acquisition.

Sprott Funds Trust. - Sprott Copper Miners ETF

Sprott Copper Miners ETF (COPP) is actively trending as the community widely discusses a potential copper supercycle driven by increasing demand from AI, electrification, and EVs. Investors are closely monitoring the implications of proposed copper import tariffs, while debating COPP's performance and its role as a key vehicle for exposure to this critical industrial metal.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO (RAVE CRYPTO) is a trending topic, primarily fueled by a news report detailing Trumps World Liberty Financial's integration of Aster Trade into its USD1 expansion, coinciding with the RAVE token achieving a record high. The community is actively discussing its breakout potential, with many expressing enthusiasm to participate in what they view as a significant rally and a potential for substantial upside, noting considerable recent trading volume.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is actively trending due to its expanding strategic partnerships with industry giants like Nvidia and Meta, positioning its energy-efficient architecture as a crucial foundation for AI advancements in data centers, robotics, and edge computing. The community is sharply divided, with many bullish on its long-term potential as an "AI power-efficiency engine" despite its high valuation, while others express frustration over recent price volatility and alleged market manipulation. This ongoing debate highlights the challenge of reconciling strong fundamental developments with short-term market action in the semiconductor sector.

DRDGOLD Ltd. engages in the business of retreatment of surface gold. The company was founded on February 16, 1895, and is headquartered in Johannesburg, South Africa.

DRDGold Ltd. - ADR

DRDGOLD Ltd.

DRDGOLD is currently a top trending stock, buoyed by surging gold prices and strong operational results that have propelled it to new 52-week highs. The community is actively celebrating its impressive year-to-date performance and discussing its debt-free balance sheet, efficient gold recovery, and disciplined management.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Evolus' (EOLS) "Hold" Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reaffirmed a "hold" rating on shares of Evolus in a research note on Wednesday...

Assenagon Asset Management S.A. Trims Position in Evolus, Inc. $EOLS

Assenagon Asset Management S.A. trimmed its stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 53.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and...

2,435,550 Shares in Evolus, Inc. $EOLS Bought by Frazier Life Sciences Management L.P.

Frazier Life Sciences Management L.P. bought a new stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) during the second quarter, according to the company in its most recent filing with the Securities...

Frontier Capital Management Co. LLC Buys 457,533 Shares of Evolus, Inc. $EOLS

Frontier Capital Management Co. LLC raised its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 37.9% in the second quarter, according to the company in its most recent disclosure with...

Stonepine Capital Management LLC Has $8.44 Million Holdings in Evolus, Inc. $EOLS

Stonepine Capital Management LLC reduced its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 19.2% during the 2nd quarter, according to its most recent disclosure with the Securities and...

Evolus, Inc. (NASDAQ:EOLS) Given Average Recommendation of "Hold" by Brokerages

Shares of Evolus, Inc. (NASDAQ:EOLS - Get Free Report) have been assigned an average rating of "Hold" from the five analysts that are covering the company, MarketBeat Ratings reports. One equities...

Evolus, Inc. $EOLS Position Cut by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. lowered its position in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 85.7% in the 2nd quarter, according to its most recent disclosure with the...

Evolus (NASDAQ:EOLS) Posts Earnings Results, Misses Expectations By $0.10 EPS

Evolus (NASDAQ:EOLS - Get Free Report) released its earnings results on Wednesday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by...

Evolus, Inc. (EOLS) Reports Q3 Loss, Beats Revenue Estimates

Evolus (EOLS) delivered earnings and revenue surprises of +26.32% and +1.70%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Prestige Consumer Healthcare (PBH) Q2 Earnings Expected to Decline

Prestige Consumer Healthcare (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.

EOLS
Evolus Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EOLS News

EOLSEvolus Inc